EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

The Potential Impact of Oral Nicotine Pouches on Public Health: A Scoping Review

Nargiz Travis iD, Kenneth E Warner, Maciej L Goniewicz, Hayoung Oh, Radhika Ranganathan iD, Rafael Meza, Jamie Hartmann-Boyce, David T Levy iD

Nicotine and Tobacco Research · 24.03.2025 · 27 (4) · 598-610

DOI: 10.1093/ntr/ntae131 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Nicotine and Tobacco Research, online erschienen am 17.06.2024. Verfasst von Nargiz Travis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Lombardi Comprehensive Cancer Center, Georgetown Medical University, Washington, DC, USA. Hauptthemen laut MEDLINE: Public Health, Nicotine, Tobacco Products. Die Arbeit wurde bisher 146-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, FDA HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Oral nicotine pouches (ONPs) are a new class of nicotine products. This scoping review summarizes evidence on ONPs and explores their potential public health impact. Aims and Methods We conducted a structured literature search for empirical studies across three electronic databases through January 10, 2024. Outcomes included ONP product characteristics, use patterns, beliefs and perceptions, toxicity, and marketing and sales.

Results

Sixty-two studies were included, 17 were industry-funded. Most studies were from the United States. While large variations across studies were observed in ONP youth prevalence estimates, nationally representative U.S. studies find current use at 1.5% and lifetime use below 2.5% through 2023. Between 35% and 42% of U.S. adolescents and young adults have heard of ONPs, and 9-21% of tobacco-naïve youth were susceptible to trying them. U.S. adult-use estimates varied widely (0.8%–3% current; 3%–16% lifetime use) and were limited to populations with a history of tobacco use. The chemical composition of ONPs suggests fewer harmful/potentially harmful compounds at lower levels than cigarettes and smokeless tobacco (SLT), except formaldehyde. Industry-funded studies find substantially less cytotoxicity compared to cigarettes and suggest that higher nicotine-strength ONPs can deliver nicotine at levels comparable to or higher than SLT or cigarettes, although with slower nicotine release than cigarettes. Evidence on the cytotoxicity of ONPs relative to SLT is mixed.

Conclusions

ONPs appear to be less toxic than cigarettes and deliver comparable nicotine, presenting an alternative for combustible product users, although key data are mainly available from industry-funded studies. Data from independent research is critically needed. Industry marketing of ONPs may encourage initiation in youth and situational and dual use in adults.

Implications

The review provides an initial assessment of the potential role of ONPs in harm reduction and aims to determine unintended consequences of their use (youth uptake and dual-use) and identify populations that disproportionately use the product. This information is essential for tobacco regulatory bodies in determining the net public health impact of nicotine pouches.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Public HealthNicotineTobacco ProductsHumansUnited StatesAdolescentYoung AdultAdult

Substanzen

Nicotine

Autor:innen und Institutionen

  • Lombardi Comprehensive Cancer Center, Georgetown Medical University, Washington, DC, USA.
  • Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
  • Department of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, BC, Canada.
  • School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
  • Department of Health Promotion and Policy, University of Massachusetts, Amherst, MA, USA.

ORCID-Profile: Nargiz Travis, Radhika Ranganathan, David T Levy

Förderung

  • NCI NIH HHS
  • FDA HHS
  • National Cancer Institute
  • Food and Drug Administration

Zitieren

APA

Travis, N., Warner, K. E., Goniewicz, M. L., Oh, H., Ranganathan, R., Meza, R., Hartmann-Boyce, J., & Levy, D. T. (2025). The Potential Impact of Oral Nicotine Pouches on Public Health: A Scoping Review. Nicotine and Tobacco Research, 27(4), 598-610. https://doi.org/10.1093/ntr/ntae131

Vancouver

Travis N, Warner KE, Goniewicz ML, Oh H, Ranganathan R, Meza R, et al. The Potential Impact of Oral Nicotine Pouches on Public Health: A Scoping Review. Nicotine and Tobacco Research. 2025;27(4):598-610. doi:10.1093/ntr/ntae131

BibTeX
@article{Travis2025,
  author = {Travis, Nargiz and Warner, Kenneth E and Goniewicz, Maciej L and Oh, Hayoung and Ranganathan, Radhika and Meza, Rafael and Hartmann-Boyce, Jamie and Levy, David T},
  title = {The Potential Impact of Oral Nicotine Pouches on Public Health: A Scoping Review},
  journal = {Nicotine and Tobacco Research},
  year = {2025},
  volume = {27},
  number = {4},
  pages = {598--610},
  doi = {10.1093/ntr/ntae131}
}
Kostenlos starten →